688553.SH
Sichuan Huiyu Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 10.94
+3.31%Year over year
Reported trailing growth
- Revenue
- -5.7%
- EBITDA
- —
- EBIT
- —
- EPS
- -91.2%
- Free cash flow
- -77.8%
- Operating cash flow
- -53.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -12.6%
- EBITDA
- -55.7%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026